FDA Recall D-0453-2026
Owen Biosciences Inc. · Baton Rouge, LA
Class II Ongoing 72 days on record
Moderate impact — Class II recall — temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.
Product
HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle; DIST BY HYDROPEPTIDE LLC, ISSAQUAH, WA 98027
Reason for recall
Chemical contamination: Presence of benzene
Recall record
- Recall number
D-0453-2026- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Letter
- Distribution
- U.S. Nationwide
- Recall initiated
- 2026-03-03
- Classified by FDA Center
- 2026-04-10
- FDA published
- 2026-04-22
- Recalling firm
- Owen Biosciences Inc.
- Firm location
- Baton Rouge, LA
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.